Hearts for Hearing
8
2
3
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
80%
4 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial
Role: collaborator
Binaural Cue Sensitivity in Children and Adults With Combined Electric and Acoustic Stimulation
Role: lead
Combined Electric and Acoustic Hearing (EAS) in Children and Adults
Role: lead
A Pediatric Comparison of Remote Microphone Technologies
Role: collaborator
Optimizing Soft Speech Recognition in Children With Hearing Loss
Role: collaborator
Benefit of Assistive Listening Device for Lateralization
Role: collaborator
Benefits of Assistive Listening Device for Speech Intelligibility
Role: collaborator
Nucleus Hybrid L24 Extended Duration Post Approval Study
Role: collaborator
All 8 trials loaded